Article
KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.
International journal of molecular sciences - 1 Apr 2016
Olmedillas López Susana, García-Olmo Dolores C, García-Arranz Mariano, Guadalajara Héctor, Pastor Carlos, García-Olmo Damián
Abstract excerpt
KRAS mutations are responsible for resistance to anti-epidermal growth factor receptor (EGFR) therapy in colorectal cancer patients. These mutations sometimes appear once treatment has started. Detection of KRAS mutations in circulating cell-free DNA in plasma ("liquid biopsy") by droplet digital PCR (ddPCR) has emerged as a very sensitive and promising alternative to serial biopsies for disease monitoring. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
